Eli Lilly and Company (LLY)
USD 764.71
(-1.79%)
USD 764.71
(-1.79%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 34.12 Billion USD | 19.56% |
| 2022 | 28.54 Billion USD | 0.79% |
| 2021 | 28.31 Billion USD | 15.4% |
| 2020 | 24.53 Billion USD | 9.95% |
| 2019 | 22.31 Billion USD | 3.84% |
| 2018 | 21.49 Billion USD | -6.03% |
| 2017 | 22.87 Billion USD | 7.77% |
| 2016 | 21.22 Billion USD | 6.33% |
| 2015 | 19.95 Billion USD | 1.75% |
| 2014 | 19.61 Billion USD | -15.13% |
| 2013 | 23.11 Billion USD | 2.25% |
| 2012 | 22.6 Billion USD | -6.93% |
| 2011 | 24.28 Billion USD | 5.25% |
| 2010 | 23.07 Billion USD | 5.68% |
| 2009 | 21.83 Billion USD | 7.15% |
| 2008 | 20.37 Billion USD | 9.36% |
| 2007 | 18.63 Billion USD | 18.75% |
| 2006 | 15.69 Billion USD | 7.14% |
| 2005 | 14.64 Billion USD | 5.68% |
| 2004 | 13.85 Billion USD | 10.14% |
| 2003 | 12.58 Billion USD | 13.59% |
| 2002 | 11.07 Billion USD | -4.03% |
| 2001 | 11.54 Billion USD | 6.26% |
| 2000 | 10.86 Billion USD | 8.59% |
| 1999 | 10 Billion USD | 8.29% |
| 1998 | 9.23 Billion USD | 8.44% |
| 1997 | 8.51 Billion USD | 15.94% |
| 1996 | 7.34 Billion USD | 8.62% |
| 1995 | 6.76 Billion USD | 18.42% |
| 1994 | 5.71 Billion USD | -11.48% |
| 1993 | 6.45 Billion USD | 4.62% |
| 1992 | 6.16 Billion USD | 7.71% |
| 1991 | 5.72 Billion USD | 10.29% |
| 1990 | 5.19 Billion USD | 24.33% |
| 1989 | 4.17 Billion USD | 2.6% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q3 | 11.43 Billion USD | 1.21% |
| 2024 Q2 | 11.3 Billion USD | 28.91% |
| 2024 Q1 | 8.76 Billion USD | -6.26% |
| 2023 Q1 | 6.96 Billion USD | -4.68% |
| 2023 Q2 | 8.31 Billion USD | 19.43% |
| 2023 FY | 34.12 Billion USD | 19.56% |
| 2023 Q3 | 9.49 Billion USD | 14.27% |
| 2023 Q4 | 9.35 Billion USD | -1.53% |
| 2022 FY | 28.54 Billion USD | 0.79% |
| 2022 Q3 | 6.94 Billion USD | 6.99% |
| 2022 Q4 | 7.3 Billion USD | 5.19% |
| 2022 Q1 | 7.81 Billion USD | -2.37% |
| 2022 Q2 | 6.48 Billion USD | -16.93% |
| 2021 Q2 | 6.74 Billion USD | -0.96% |
| 2021 Q3 | 6.77 Billion USD | 0.49% |
| 2021 Q4 | 7.99 Billion USD | 18.12% |
| 2021 FY | 28.31 Billion USD | 15.4% |
| 2021 Q1 | 6.8 Billion USD | -8.53% |
| 2020 Q4 | 7.44 Billion USD | 29.6% |
| 2020 Q1 | 5.85 Billion USD | -4.16% |
| 2020 Q2 | 5.49 Billion USD | -6.15% |
| 2020 FY | 24.53 Billion USD | 9.95% |
| 2020 Q3 | 5.74 Billion USD | 4.39% |
| 2019 Q4 | 6.11 Billion USD | 11.64% |
| 2019 Q1 | 5.09 Billion USD | -20.91% |
| 2019 Q2 | 5.63 Billion USD | 10.69% |
| 2019 FY | 22.31 Billion USD | 3.84% |
| 2019 Q3 | 5.47 Billion USD | -2.84% |
| 2018 FY | 21.49 Billion USD | -6.03% |
| 2018 Q2 | 6.35 Billion USD | 11.49% |
| 2018 Q3 | 6.06 Billion USD | -4.62% |
| 2018 Q1 | 5.7 Billion USD | -7.48% |
| 2018 Q4 | 6.43 Billion USD | 6.21% |
| 2017 Q2 | 5.82 Billion USD | 11.4% |
| 2017 Q4 | 6.16 Billion USD | 8.88% |
| 2017 FY | 22.87 Billion USD | 7.77% |
| 2017 Q1 | 5.22 Billion USD | -9.24% |
| 2017 Q3 | 5.65 Billion USD | -2.86% |
| 2016 Q4 | 5.76 Billion USD | 10.96% |
| 2016 Q2 | 5.4 Billion USD | 11.09% |
| 2016 Q3 | 5.19 Billion USD | -3.94% |
| 2016 FY | 21.22 Billion USD | 6.33% |
| 2016 Q1 | 4.86 Billion USD | -9.5% |
| 2015 Q4 | 5.37 Billion USD | 8.39% |
| 2015 FY | 19.95 Billion USD | 1.75% |
| 2015 Q1 | 4.64 Billion USD | -9.31% |
| 2015 Q2 | 4.97 Billion USD | 7.19% |
| 2015 Q3 | 4.95 Billion USD | -0.38% |
| 2014 Q2 | 4.93 Billion USD | 5.39% |
| 2014 FY | 19.61 Billion USD | -15.13% |
| 2014 Q1 | 4.68 Billion USD | -19.38% |
| 2014 Q3 | 4.87 Billion USD | -1.22% |
| 2014 Q4 | 5.12 Billion USD | 5.04% |
| 2013 Q3 | 5.77 Billion USD | -2.65% |
| 2013 Q4 | 5.8 Billion USD | 0.63% |
| 2013 FY | 23.11 Billion USD | 2.25% |
| 2013 Q1 | 5.6 Billion USD | -5.96% |
| 2013 Q2 | 5.92 Billion USD | 5.85% |
| 2012 Q2 | 5.6 Billion USD | -0.02% |
| 2012 Q4 | 5.95 Billion USD | 9.44% |
| 2012 Q3 | 5.44 Billion USD | -2.81% |
| 2012 Q1 | 5.6 Billion USD | -7.35% |
| 2012 FY | 22.6 Billion USD | -6.93% |
| 2011 Q1 | 5.83 Billion USD | -5.62% |
| 2011 Q3 | 6.14 Billion USD | -1.68% |
| 2011 Q4 | 6.04 Billion USD | -1.65% |
| 2011 Q2 | 6.25 Billion USD | 7.08% |
| 2011 FY | 24.28 Billion USD | 5.25% |
| 2010 FY | 23.07 Billion USD | 5.68% |
| 2010 Q3 | 5.65 Billion USD | -1.63% |
| 2010 Q4 | 6.18 Billion USD | 9.41% |
| 2010 Q1 | 5.48 Billion USD | -7.56% |
| 2010 Q2 | 5.74 Billion USD | 4.8% |
| 2009 Q4 | 5.93 Billion USD | 6.69% |
| 2009 Q2 | 5.29 Billion USD | 4.87% |
| 2009 Q3 | 5.56 Billion USD | 5.09% |
| 2009 Q1 | 5.04 Billion USD | -3.14% |
| 2009 FY | 21.83 Billion USD | 7.15% |
| 2008 Q1 | 4.8 Billion USD | -7.36% |
| 2008 Q3 | 5.2 Billion USD | 1.15% |
| 2008 Q2 | 5.15 Billion USD | 7.13% |
| 2008 Q4 | 5.21 Billion USD | 0.02% |
| 2008 FY | 20.37 Billion USD | 9.36% |
| 2007 Q4 | 5.18 Billion USD | 13.14% |
| 2007 FY | 18.63 Billion USD | 18.75% |
| 2007 Q1 | 4.22 Billion USD | -0.45% |
| 2007 Q2 | 4.63 Billion USD | 9.58% |
| 2007 Q3 | 4.58 Billion USD | -0.95% |
| 2006 FY | 15.69 Billion USD | 7.14% |
| 2006 Q4 | 4.24 Billion USD | 9.87% |
| 2006 Q3 | 3.86 Billion USD | -0.07% |
| 2006 Q2 | 3.86 Billion USD | 4.1% |
| 2006 Q1 | 3.71 Billion USD | -4.24% |
| 2005 Q2 | 3.66 Billion USD | 4.87% |
| 2005 Q3 | 3.6 Billion USD | -1.82% |
| 2005 Q4 | 3.87 Billion USD | 7.72% |
| 2005 FY | 14.64 Billion USD | 5.68% |
| 2005 Q1 | 3.49 Billion USD | -4.03% |
| 2004 Q1 | 3.37 Billion USD | -2.56% |
| 2004 Q3 | 3.28 Billion USD | -7.76% |
| 2004 Q4 | 3.64 Billion USD | 11.09% |
| 2004 FY | 13.85 Billion USD | 10.14% |
| 2004 Q2 | 3.55 Billion USD | 5.31% |
| 2003 Q2 | 3.08 Billion USD | 6.88% |
| 2003 Q1 | 2.88 Billion USD | -2.24% |
| 2003 Q3 | 3.13 Billion USD | 1.66% |
| 2003 Q4 | 3.46 Billion USD | 10.39% |
| 2003 FY | 12.58 Billion USD | 13.59% |
| 2002 Q1 | 2.56 Billion USD | -9.47% |
| 2002 Q4 | 2.95 Billion USD | 6.1% |
| 2002 Q3 | 2.78 Billion USD | 0.37% |
| 2002 FY | 11.07 Billion USD | -4.03% |
| 2002 Q2 | 2.77 Billion USD | 8.36% |
| 2001 Q1 | 2.8 Billion USD | -5.78% |
| 2001 Q4 | 2.82 Billion USD | -1.58% |
| 2001 FY | 11.54 Billion USD | 6.26% |
| 2001 Q3 | 2.87 Billion USD | -5.24% |
| 2001 Q2 | 3.03 Billion USD | 8.12% |
| 2000 Q3 | 2.81 Billion USD | 7.26% |
| 2000 Q1 | 2.45 Billion USD | -13.1% |
| 2000 FY | 10.86 Billion USD | 8.59% |
| 2000 Q2 | 2.62 Billion USD | 6.95% |
| 2000 Q4 | 2.97 Billion USD | 5.9% |
| 1999 Q1 | 2.25 Billion USD | 9.83% |
| 1999 Q3 | 2.58 Billion USD | 10.4% |
| 1999 Q4 | 2.82 Billion USD | 9.1% |
| 1999 FY | 10 Billion USD | 8.29% |
| 1999 Q2 | 2.34 Billion USD | 3.81% |
| 1998 Q4 | 2.05 Billion USD | -20.18% |
| 1998 Q3 | 2.57 Billion USD | 9.93% |
| 1998 Q2 | 2.34 Billion USD | 3.16% |
| 1998 Q1 | 2.26 Billion USD | -6.07% |
| 1998 FY | 9.23 Billion USD | 8.44% |
| 1997 Q4 | 2.41 Billion USD | 11.84% |
| 1997 Q1 | 1.95 Billion USD | -5.24% |
| 1997 Q2 | 1.98 Billion USD | 1.83% |
| 1997 Q3 | 2.16 Billion USD | 8.62% |
| 1997 FY | 8.51 Billion USD | 15.94% |
| 1996 Q3 | 1.8 Billion USD | 6.22% |
| 1996 Q4 | 2.06 Billion USD | 14.26% |
| 1996 FY | 7.34 Billion USD | 8.62% |
| 1996 Q1 | 1.78 Billion USD | -0.92% |
| 1996 Q2 | 1.69 Billion USD | -4.77% |
| 1995 Q4 | 1.79 Billion USD | 10.29% |
| 1995 FY | 6.76 Billion USD | 18.42% |
| 1995 Q3 | 1.63 Billion USD | 1.06% |
| 1995 Q2 | 1.61 Billion USD | -5.97% |
| 1995 Q1 | 1.71 Billion USD | 196.75% |
| 1994 Q4 | 578.7 Million USD | -68.16% |
| 1994 Q1 | 1.63 Billion USD | -9.1% |
| 1994 FY | 5.71 Billion USD | -11.48% |
| 1994 Q2 | 1.67 Billion USD | 2.54% |
| 1994 Q3 | 1.81 Billion USD | 8.28% |
| 1993 Q3 | 1.53 Billion USD | -1.95% |
| 1993 Q2 | 1.56 Billion USD | 0.06% |
| 1993 Q1 | 1.56 Billion USD | -5.76% |
| 1993 FY | 6.45 Billion USD | 4.62% |
| 1993 Q4 | 1.8 Billion USD | 17.65% |
| 1992 Q1 | 1.55 Billion USD | -0.99% |
| 1992 Q3 | 1.47 Billion USD | -0.12% |
| 1992 Q2 | 1.47 Billion USD | -5.06% |
| 1992 FY | 6.16 Billion USD | 7.71% |
| 1992 Q4 | 1.65 Billion USD | 12.12% |
| 1991 FY | 5.72 Billion USD | 10.29% |
| 1991 Q3 | 1.34 Billion USD | -2.54% |
| 1991 Q2 | 1.37 Billion USD | -4.12% |
| 1991 Q4 | 1.57 Billion USD | 17.24% |
| 1991 Q1 | 1.43 Billion USD | -0.57% |
| 1990 FY | 5.19 Billion USD | 24.33% |
| 1990 Q2 | 1.22 Billion USD | -1.23% |
| 1990 Q4 | 1.44 Billion USD | 12.64% |
| 1990 Q1 | 1.24 Billion USD | 58.24% |
| 1990 Q3 | 1.28 Billion USD | 4.6% |
| 1989 FY | 4.17 Billion USD | 2.6% |
| 1989 Q1 | 1.22 Billion USD | 17.53% |
| 1989 Q3 | 1.04 Billion USD | -6.81% |
| 1989 Q2 | 1.12 Billion USD | -8.45% |
| 1989 Q4 | 784 Million USD | -24.98% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| AbbVie Inc. | 54.31 Billion USD | 37.177% |
| Bristol-Myers Squibb Company | 45 Billion USD | 24.179% |
| Bristol-Myers Squibb Company Ce | 45 Billion USD | 24.179% |
| Johnson & Johnson | 85.15 Billion USD | 59.929% |
| Merck & Co., Inc. | 60.11 Billion USD | 43.235% |
| Novartis AG | 46.66 Billion USD | 26.866% |
| Organon & Co. | 6.26 Billion USD | -444.852% |
| Pfizer Inc. | 58.49 Billion USD | 41.664% |